BSE
USFDA issues form 483 with six observations to Glenmark
The U.S. FDA has issued Form 483 with six observations after an inspection at Glenmark Pharmaceuticals Limited's formu…
The U.S. FDA has issued Form 483 with six observations after an inspection at Glenmark Pharmaceuticals Limited's formu…
Our website uses cookies to improve your experience. Learn more
Ok